Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int. braz. j. urol ; 49(6): 783-784, Nov.-Dec. 2023.
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1550285

RESUMEN

ABSTRACT Introduction: The En-bloc Resection of Bladder Tumors (ERBT) is a method that offers more benefits compared to the traditional Transurethral Resection of Bladder Tumor (TURBT) (1, 2). Recent studies have shown that ERBT offers better pathological analysis and oncological outcomes (3-6). Thulium and holmium are the most frequently used lasers for this procedure, with the hybrid laser being a new addition that combines thulium and diode to improve hemostatic properties (5, 7-9). Objective: This report aims to discuss the use of two types of lasers, hybrid and holmium, for ERBT. Material and Methods: Two case studies were conducted. The first case featured a 68-year-old male with two tumors measuring 1.5cm and 2cm. The hybrid laser was used for the procedure. The second case involved a 70-year-old female with a 5cm tumor on the posterior bladder wall, and holmium laser was used with morcellation of the tumor. The quality of histopathological analysis was evaluated. The perioperative data and the entire procedure of the two cases were documented in a step-by-step video. Results: Both lasers demonstrated excellent results without technical difficulties. There was no bleeding, and both patients were discharged with one day of hospitalization. The detrusor muscle was present without artifacts, and the morcellation did not affect the analysis. The first case showed a pT1G3, and the second case showed a pT2 urothelial carcinoma. The hybrid laser exhibited superior hemostatic capacity compared to the holmium laser. Conclusion: ERBT can use hybrid or holmium lasers without affecting histopathological analysis, even with morcellation.

3.
Int. braz. j. urol ; 44(4): 765-770, July-Aug. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-954087

RESUMEN

ABSTRACT Introduction: The urinary bladder diverticula (BD) secondary to benign prostatic hyperplasia (BPH) is a complication that can lead to urinary stasis, stone, urinary tract infection (UTI) and tumors. It's role in acute urinary retention (AUR) is not totally understood. Objectives: To determine the effect of BD size on AUR rates in patients with BPH candidates to surgery. Subjects and Methods: We performed a retrospective cohort study of 47 patients with BPH and BD who underwent BPH surgery associated to complete bladder diverticulectomy from 2006 to 2016. We analyzed risk factors for AUR in patients with BD using univariate, multivariate and correlation analysis. Results: There was a difference in the size of the diverticula, with 6.8 cm vs. 4.5 cm among patients with and without AUR respectively (p=0.005). The ROC curve showed a correlation between the size of BD and the risk of AUR. The value of 5.15 cm presented a sensitivity of 73% and a specificity of 72%. The area under the curve was 0.75 (p=0.01). Comparing groups with BD >5.0 cm vs. ≤5.0 cm, the AUR incidence was 74% and 27.8% respectively with an OR of 2.65 (1.20-5.85) (p=0.005). In the multivariate analysis, only the size of the diverticula reached statistical significance (p=0.012). Conclusions: The diameter of BD is an independent risk factor for AUR in patients with BPH and BD who are candidates to surgery. A diameter greater than 5.15 cm increases the risk of AUR.


Asunto(s)
Humanos , Masculino , Anciano , Hiperplasia Prostática/cirugía , Hiperplasia Prostática/complicaciones , Vejiga Urinaria/anomalías , Retención Urinaria/etiología , Divertículo/complicaciones , Divertículo/patología , Valores de Referencia , Vejiga Urinaria/patología , Vejiga Urinaria/diagnóstico por imagen , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X , Enfermedad Aguda , Estudios Retrospectivos , Factores de Riesgo , Curva ROC , Divertículo/diagnóstico por imagen , Medición de Riesgo , Persona de Mediana Edad
4.
Int. braz. j. urol ; 41(6): 1088-1095, Nov.-Dec. 2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-769768

RESUMEN

Introduction and objective: Overexpression of MMPs has been related to biochemical recurrence after radical prostatectomy. TIMP1 and TIMP2 are controllers of MMPs and the aim of this study is to evaluate the expression levels of MMPs and their regulators using immunohistochemistry in tissue microarray of localized prostate cancer (PC). Materials and Methods: Immune-expression of MMP-9, MMP-2, TIMP1, TIMP-2, MMP-14 and IL8, were analyzed by immunohistochemistry in radical prostatectomy specimens of 40 patients with localized PC who underwent surgery between September 1997 and February 2000. Protein expression was considered as categorical variables, negative or positive. The results of the immune-expression were correlated to Gleason score (GS), pathological stage (TNM), pre-operatory PSA serum levels and biochemical recurrence in a mean follow up period of 92.5 months. Results: The loss of TIMP1 immune-expression was related to biochemical recurrence. When TIMP1 was negative, 56.3% patients recurred versus 22.2% of those whose TIMP1 was positive (p=0.042). MMP-9, MMP-2, IL8 and MMP-14 were positive in the majority of PC. TIMP-2 was negative in all cases. Conclusion: Negative immune-expression of TIMP1 is correlated with biochemical recurrence in patients with PC possibly by failing to control MMP-9, an important MMP related to cancer progression.


Asunto(s)
Adulto , Anciano , Humanos , Masculino , Persona de Mediana Edad , Metaloproteinasas de la Matriz/análisis , Recurrencia Local de Neoplasia/patología , Neoplasias de la Próstata/patología , Inhibidor Tisular de Metaloproteinasa-1/análisis , /análisis , Biomarcadores de Tumor/análisis , Progresión de la Enfermedad , Inmunohistoquímica , /análisis , Estimación de Kaplan-Meier , Clasificación del Tumor , Estadificación de Neoplasias , Recurrencia Local de Neoplasia/química , Prostatectomía , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/química , Neoplasias de la Próstata/cirugía , Estadísticas no Paramétricas
5.
Rev. med. (Säo Paulo) ; 86(1): 20-27, jan.-mar. 2007. ilus, graf
Artículo en Portugués | LILACS | ID: lil-498351

RESUMEN

A hérnia diafragmática congênita (HDC) causa hipoplasia e hipertensãopulmonar e em geral leva a alta morbidade e mortalidade neonatal. Traqueo-oclusão fetal (TO) e corticoterapia pré-natal são alternativas para acelerar o crescimento pulmonar fetal e diminuir a hipoplasia na HDC. A produção de VEGF (Vascular Endothelial Growth Factor) está relacionada com a maturidade pulmonar e sofre alterações na HDC ainda não elucidadas.Materiais e métodos: Seis grupos de 12 fetos de ratos Spreague-Dawley foram comparados: TO, Sham, Controle, TO+Dex, Sham+Dex e Controle+Dex. No dia 18,5º foi realizada TO come sem corticoterapia utilizando dexametasona. No 21,5º dia gestacional os pesos corporal e...


Congenital diaphragmatic hernia (CDH) presents with hypoplastic lungs and usually leads to pulmonary hypertension and high neonatal mortality. Fetal tracheal occlusion (TO) and prenatal corticotherapy are alternatives to accelerate fetal pulmonary growth and decrease hypoplasia in CDH. VEGF (Vascular Endothelial Growth Factor)production and surfactant production by type II pneumocytes are related with pulmonary maturity and are altered in CDH, but little has been described about VEGF receptors. Our objective wasto quantify the receptors of VEGF (VEGFR) and type II pneumocytes, verifying the effects of TO and corticotherapy on normal lungs of fetal rats...


Asunto(s)
Hipertensión Pulmonar/prevención & control , Hernia Diafragmática/congénito , Inmunohistoquímica , Modelos Animales , Corticoesteroides , Hipertensión Pulmonar/mortalidad , Hernia Diafragmática/cirugía , Hernia Diafragmática/complicaciones , Hernia Diafragmática/diagnóstico , Mortalidad Infantil
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA